FI49517C - Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi.

Info

Publication number
FI49517C
FI49517C FI691673A FI167369A FI49517C FI 49517 C FI49517 C FI 49517C FI 691673 A FI691673 A FI 691673A FI 167369 A FI167369 A FI 167369A FI 49517 C FI49517 C FI 49517C
Authority
FI
Finland
Prior art keywords
ergopeptin
dihydro
beta
isopropyl
propyl
Prior art date
Application number
FI691673A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI49517B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Stephan Guttmann
Rene Huguenin
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI49517B publication Critical patent/FI49517B/fi
Application granted granted Critical
Publication of FI49517C publication Critical patent/FI49517C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI691673A 1968-06-25 1969-06-04 Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi. FI49517C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH951568A CH508628A (de) 1968-06-25 1968-06-25 Verfahren zur Herstellung neuer heterocyclischer Verbindungen

Publications (2)

Publication Number Publication Date
FI49517B FI49517B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-01
FI49517C true FI49517C (fi) 1975-07-10

Family

ID=4352804

Family Applications (1)

Application Number Title Priority Date Filing Date
FI691673A FI49517C (fi) 1968-06-25 1969-06-04 Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi.

Country Status (17)

Country Link
US (1) US3666762A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT308288B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE734999A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR6910095D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA947291A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH508628A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1931081A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK127644B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES368721A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI49517C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2011659A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1266744A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL32462A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6908302A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL80112B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE355810B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU372813A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298277A (en) * 1969-04-18 1972-11-29 Sandoz Ltd Preparation of ergot peptide alkaloids
US3846433A (en) * 1969-05-06 1974-11-05 Sandoz Ltd Process for preparing ergot alkaloids
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
WO2012177962A1 (en) 2011-06-23 2012-12-27 Map Pharmaceuticals, Inc. Novel fluoroergoline analogs
EP2793580A4 (en) 2011-12-19 2015-05-20 Map Pharmaceuticals Inc NEW DERIVATIVES OF ISO-ERGOLINE
WO2013095708A1 (en) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
GB1011112A (en) * 1961-05-10 1965-11-24 Sandoz Ag Improvements in or relating to ergot alkaloids
CH395119A (de) * 1961-05-10 1965-07-15 Sandoz Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
FR1583797A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1967-04-12 1969-12-05

Also Published As

Publication number Publication date
FI49517B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-01
GB1266744A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-15
AT308288B (de) 1973-06-25
FR2011659A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-03-06
DK127644B (da) 1973-12-10
BR6910095D0 (pt) 1973-02-08
SE355810B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-05-07
US3666762A (en) 1972-05-30
CA947291A (en) 1974-05-14
NL6908302A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-12-30
BE734999A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-12-23
IL32462A (en) 1973-07-30
DE1931081A1 (de) 1970-01-15
CH508628A (de) 1971-06-15
PL80112B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-30
ES368721A1 (es) 1971-06-16
SU372813A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-03-01
IL32462A0 (en) 1969-08-27

Similar Documents

Publication Publication Date Title
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI52221C (fi) Menetelmä antibakteeristen 1,4-dihydro-4-okso-7-pyridyyli-3-kinoliinik arboksyylihappojohdannaisten valmistamiseksi.
FI52574C (fi) Menetelmä farmakologisesti arvokkaiden substituoitujen N-allyyli-2-fen yyliamino-imidatsoliinien-(2) valmistamiseksi.
FI49716C (fi) Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi.
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
FI46166C (fi) Menetelmä teknisesti käyttökelpoisten 2,4,6,8,9-penta-atsa-bisyklo-/3. 3.1/-nona-2,6-dieenien valmistamiseksi.
FI49517C (fi) Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI46374C (fi) Menetelmä 2'-substituoitujen steroidi-(17alfa,16alfa-d)-oksatsoliinien valmistamiseksi.
FI51700C (fi) Menetelmä rauhoittavina lääkeaineina käyttökelpoisten 6-fenyyli-4H-s-t riatsolo-(1,5a)(1,4)-bentsodiatsepiinien valmistamiseksi.
FI49161C (fi) Menetelmä kardenolidi-3-(2´,3´-didesoksi-2´,3´-oksido-glykosidien) val mistamiseksi.
FI46844C (fi) Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi.
FI51183C (fi) Menetelmä 2-hydroksimetyyli-3-karbonihappoamido-kinoksaliini-di-N-oksi de-(1,4)-yhdisteiden valmistamiseksi.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI49417C (fi) Menetelmä farmakologisesti aktiivisten 2,3-dihydro-bentsofuraani-2-kar bonihappojen valmistamiseksi.
FI52096C (fi) Menetelmä analgeettisesti aktiivisten 2,3-dihydrotiatsolo(3.2.a)pyrimi diini-5-onien valmistamiseksi
FI46724C (fi) Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi.
FI47358C (fi) Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi.
FI52581C (fi) Menetelmä terapeuttisesti käytettävien N-(1,1-ditienyyli-propyyli-(3)) -fenyylietyyliamiinien valmistamiseksi.
FI50710C (fi) Menetelmä 1,4-bentsodiatsepiinien valmistamiseksi.
FI46385C (fi) Menetelmä terapeuttisesti arvokkaiden 1,3-dihydro-3-hydroksi-2H-1,4-be ntsodiatsepiini-2-onijohdannaisten valmistamiseksi.
FI48732C (fi) Menetelmä farmakologisesti aktiivisten 3-substituoitu-amino-1,2,3,4-te trahydrokarbatsolien valmistamiseksi.
FI51699C (fi) Menetelmä 6-fenyyli-4H-s-triatsolo-(4,3a)(1,4)-bentsodiatsepiinijohdan naisten valmistamiseksi.
FI51814C (fi) Menetelmä alfa-karboksibentsyylipenisiliinin kielteisen alkalimetallis uolojen valmistamiseksi.
FI48469C (fi) Menetelmä 1,4-bentsodiatsepiinijohdannaisten valmistamiseksi.